[DPHARMA] YoY Annualized Quarter Result on 30-Sep-2017 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- 6.23%
YoY- 62.3%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 581,088 584,942 510,784 474,312 318,542 241,705 167,916 22.96%
PBT 74,248 75,826 56,010 51,961 33,573 42,968 43,452 9.33%
Tax -17,692 -18,173 -11,648 -11,518 -9,580 -11,714 -10,685 8.75%
NP 56,556 57,653 44,362 40,442 23,993 31,253 32,766 9.51%
-
NP to SH 56,556 57,653 44,362 40,829 25,156 31,253 32,766 9.51%
-
Tax Rate 23.83% 23.97% 20.80% 22.17% 28.53% 27.26% 24.59% -
Total Cost 524,532 527,289 466,421 433,869 294,549 210,452 135,149 25.33%
-
Net Worth 584,565 505,919 501,487 474,230 451,913 268,509 187,436 20.85%
Dividend
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Div 4,639 8,994 13,197 - - - 7,404 -7.48%
Div Payout % 8.20% 15.60% 29.75% - - - 22.60% -
Equity
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Net Worth 584,565 505,919 501,487 474,230 451,913 268,509 187,436 20.85%
NOSH 706,026 680,106 661,881 278,959 278,959 278,959 138,841 31.10%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 9.73% 9.86% 8.69% 8.53% 7.53% 12.93% 19.51% -
ROE 9.67% 11.40% 8.85% 8.61% 5.57% 11.64% 17.48% -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 83.50 86.71 77.41 170.03 114.19 144.93 120.94 -5.98%
EPS 8.21 8.65 6.79 14.49 8.60 18.72 23.60 -16.12%
DPS 0.67 1.33 2.00 0.00 0.00 0.00 5.33 -29.20%
NAPS 0.84 0.75 0.76 1.70 1.62 1.61 1.35 -7.59%
Adjusted Per Share Value based on latest NOSH - 278,959
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 60.41 60.81 53.10 49.31 33.11 25.13 17.46 22.95%
EPS 5.88 5.99 4.61 4.24 2.62 3.25 3.41 9.49%
DPS 0.48 0.93 1.37 0.00 0.00 0.00 0.77 -7.56%
NAPS 0.6077 0.5259 0.5213 0.493 0.4698 0.2791 0.1949 20.84%
Price Multiplier on Financial Quarter End Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 -
Price 3.16 1.40 1.23 2.20 2.06 2.72 3.17 -
P/RPS 3.78 1.61 1.59 1.29 1.80 1.88 2.62 6.29%
P/EPS 38.88 16.38 18.30 15.03 22.84 14.51 13.43 19.36%
EY 2.57 6.10 5.47 6.65 4.38 6.89 7.44 -16.22%
DY 0.21 0.95 1.63 0.00 0.00 0.00 1.68 -29.26%
P/NAPS 3.76 1.87 1.62 1.29 1.27 1.69 2.35 8.14%
Price Multiplier on Announcement Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 12/11/20 29/11/19 28/11/18 17/11/17 21/11/16 24/11/15 21/11/14 -
Price 4.04 1.39 1.07 2.20 2.10 2.70 3.01 -
P/RPS 4.84 1.60 1.38 1.29 1.84 1.86 2.49 11.70%
P/EPS 49.71 16.26 15.92 15.03 23.29 14.41 12.75 25.42%
EY 2.01 6.15 6.28 6.65 4.29 6.94 7.84 -20.27%
DY 0.17 0.96 1.87 0.00 0.00 0.00 1.77 -32.30%
P/NAPS 4.81 1.85 1.41 1.29 1.30 1.68 2.23 13.65%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment